Biogen: CEO Departing; Is This Drug Maker In Play?
July 21, 2016 at 10:02 AM EDT
Bloomberg News/Scott Eisen There is no shortage of big news out of Biogen (BIIB) today. The announcement that CEO George Scangos would be leaving in the coming months, comes as the drug maker topped second-quarter forecasts, provided an upbeat earnings outlook and unveiled a $5 billion share buyback. Biogen shares, down 14% this year through […]
